In the course of a systematic genomic survey, 22 mani-depressive (bipolar) families were ea for linkage to 11 chromosome 18 pericentromeric marker loci, under dominant and recessive models. Overall logarithm of odds score analysis for the pedigree series was not s cant under either model, but several families yielded logarithm of odds scores consistent with linkage under dominant or recessive models.
Evidence from twin, family, and adoption studies suggests that bipolar (BP) illness is, in part, a heritable disease (1) . Linkage studies of BP disorder have been conducted to localize causative genes; however, no confirmed linkages have been established. Evidence for a BP gene on llplS (2) has been discounted by failure to replicate the finding in numerous other pedigrees (3) (4) (5) (6) and by evaluation of newly ascertained individuals in the original pedigree (7) . The color-vision region of Xq28 also has been reported linked to BP illness (8) (9) (10) (11) . Again, however, several investigators have not confirmed this linkage (12) (13) (14) (15) . One (11) of the most positive original findings [logarithm of odds (lod) score of 9 in four Israeli pedigrees for clinically assessed color blindness and glucose-6-phosphate dehydrogenase deficiency] could not be replicated by molecular genotyping with relevant Xq28 DNA markers (16) .
It has been suggested that failures of linkage replication may reflect statistical artifacts of multiple testing, false rejection of linkage due to misspecification of the genetic model, and low statistical power to detect linkage (17) . Some nonparametric analytic approaches, including affected sibling pair [ASP (18) ] and affected pedigree member [APM (19) ] methods, do not require specification of the genetic model of illness inheritance and, thus, may be appropriate for complex diseases (see below).
We have been conducting a genomic search for BP vulnerability genes, using a series of multiplex BP families (20) (21) (22) . We report here results for analysis of several pericentromeric chromosome 18 DNA markers (23) A minisatellite probe (cMS615) for locus D18S32 was a gift from John Armour (University of Leiceister, U.K.). Although it has not been placed on any published linkage map, preliminary evidence placed it in this region (27) . Genotyping methods for D18S32 (using Southern blots of genomic DNA digested with Hinfl) and D18S21 (probe pHHH163) have been described (21 (28) .
Nonparametric methods were also applied to these data. We computed the ASP statistics that test whether ASPs have a mean proportion of marker genes identical-by-descent that is >0.50 (18) . The sib-pair statistics were computed (using all of the available data on the sibship and their parents) by using the SIBPAL program of the SAGE package (29) . These statistics are computed on all possible affected pairs. This procedure may inflate the contribution of sibships with large numbers of affected individuals. To partially correct for this, we modified the degrees of freedom of the t test to be the number of independent affected pairs (defined per sibship as the number of affected individuals minus 1) in the sample instead of the number of all possible pairs (30) .
An APM analysis was applied to these data (19, 31 (32) . These allele frequencies were estimated from the studied pedigrees by using the method of Boehnke (33) or by counting alleles.
Significance of the APM test statistic is calculated from the theoretical (normal) distribution of the statistic. In addition, 10,000 replicates of these data, assuming independent inheritance of marker alleles and disease (i.e., no linkage), were simulated to assess the probability of observing the actual results (or a more extreme statistic) by chance. This probability is the empirical P value. Each replicate is generated by simulating an unlinked marker segregating through the actual pedigrees. An APM statistic is generated by analyzing the simulated data set exactly as the actual data set was analyzed. The rank of the observed statistic in the distribution of the simulated statistics determines the empirical P value.
A multilocus APM analysis was computed on these data (31 (Table 3) . DISCUSSION Positive lod scores were observed for chromosome 18 pericentromeric markers under dominant or recessive models of inheritance for several pedigrees. However, significant evidence among all pedigrees for linkage and heterogeneity, using the lod score method, was not observed. The APM statistics ( Table 3 ) provide evidence that a gene that increases susceptibility to BP illness is present in this region of chromosome 18 . The ASP analysis is consistent with this hypothesis (Table 2) .
It should be noted that the ASP statistic is computed on all possible pairs within a sibship. A simulation by Suarez and Van Eerdewegh (30) showed an increase in the type I error for an ASP statistic based on all possible pairs. However, when the statistic was weighted for sibship size, the type I error was generally not increased. In this study, we have corrected the degrees of freedom of the ASP tests to reflect the total number of independent affected pairs, but the statistics are not weighted by sibship size.
The fact that the nonparametric results have higher significance than the lod-score results may indicate complex inheritance (or small effect) of the susceptibility locus since the lod score method is not powerful for detecting genes with "6small" effects (35) . Whatever the origins of these results, this evidence for a BP susceptibility gene must be confirmed in an independent set of families.
The fact that positive lod scores at the same loci were observed in separate families for recessive or dominant models ofinheritance raises the question ofwhether different mutations at the same locus could produce diseases segregating differently, as dominant or recessive. Different mutations in the growth hormone gene (GHI) have been described for two forms (one dominant and the other recessive) of familial growth hormone deficiency (36) . Thus, there is evidence that different mutations in one gene may produce clinically similar diseases that appear to be transmitted in dominant or recessive modes. We must also admit the possibility that the significant results could be a false positive. On the other hand, ifwe have identified a locus with relatively "small" effects, it may be very difficult to replicate these findings. Suarez et al. (37) have shown that when a locus that is part of a system of additive loci is identified by linkage analysis hundreds of independent families may be necessary to replicate the finding.
While the evidence presented here is consistent with a BP susceptibility gene near the centromere of chromosome 18, the data do not permit accurate localization of a linked interval. Certainly within the region examined (which spans 50 cM), multiple candidate genes (most of which are unidentified) must exist.
Two candidate genes in this region deserve mention, the first being a gene for the a subunit of a GTP binding protein that (when associated with 83 and y subunits) transduces neurotransmitter receptor activation into second messenger system changes within the neuron (38) . Lithium (an effective treatment for BP illness) inhibits the function of a subunits by decreasing the affinity with which the a subunit binds GTP (39) , and antidepressants modulate the expression of GTP binding protein genes in brain (40) . A gene for the a subunit of a GTP binding protein (41) has been localized to the 18pll region (42) . Immunocytochemical and Northern blot hybridization experiments suggest that this a subunit, Gov, may be expressed only in nasal epithelium and in limited regions of mammalian brain, including olfactory tract, bulb, and tubercle, nucleus accumbens, striatum, and substantia nigra (43) .
The second candidate gene is a corticotropin (ACTH) receptor gene. Disturbances of hypothalamic-pituitaryadrenal axis function have often been described in patients with mood disorders. These abnormalities include hypercortisolemia (with loss of the normal circadian rhythm and failure to suppress plasma cortisol after dexamethasone administration), enlarged adrenal glands, elevated cerebrospinal fluid corticotropin-releasing factor levels, and a blunted ACTH response to exogenous administration of corticotropin-releasing factor (44) . An 
